This calculator computes adjusted body weight (AjBW) as ideal body weight + 0.4 × (actual − ideal). Use AjBW in the Cockcroft–Gault creatinine clearance equation when a patient is obese, because total body weight overestimates clearance.
What Is Adjusted Body Weight?
Adjusted body weight (AjBW) is a dosing weight for obese patients that sits between ideal and total body weight. Total body weight overstates the size of the compartment that clears many drugs, because adipose tissue contributes far less to creatinine production and drug handling than lean mass. Plugging total body weight into the Cockcroft–Gault creatinine clearance equation therefore overestimates clearance in obesity. AjBW corrects for this by adding back only part of the excess weight.
The Adjusted Body Weight Formula
The formula is AjBW = IBW + 0.4 × (actual − IBW). Each term is defined: IBW is ideal body weight from the Devine formula; actual is the patient's total (measured) body weight; and the difference (actual − IBW) is the excess weight above ideal. The 0.4 factor adds back 40% of that excess, reflecting the limited contribution of adipose tissue. The result always falls between IBW and actual weight.
Worked Example
Take a patient with an ideal body weight of 70 kg and an actual weight of 120 kg. The excess is 120 − 70 = 50 kg. AjBW = 70 + 0.4 × 50 = 70 + 20 = 90 kg. You would enter 90 kg — not 120 kg — as the weight in the Cockcroft–Gault equation, which keeps the creatinine clearance estimate from being inflated by fat mass.
When to Use Adjusted Body Weight
Use AjBW when actual weight exceeds roughly 1.2× ideal body weight. The full rule for choosing a dosing weight is:
| Situation | Weight to use |
|---|---|
| Actual weight below IBW | actual (total) body weight |
| Actual roughly normal-to-lean | ideal body weight (IBW) |
| Obese (actual > ~1.2× IBW) | adjusted body weight (AjBW) |
For normal-to-lean patients, use IBW; when actual weight is below IBW, use actual weight. See creatinine clearance in obesity for the full discussion.
Limitations and Edge Cases
- Not for normal-weight patients: below ~1.2× IBW, AjBW offers no advantage over IBW.
- The 0.4 factor is an approximation: it is a widely used convention, not an exact physiological constant, and some agents use different correction factors.
- Requires a valid IBW: AjBW depends on Devine IBW, which is not validated below 5 feet of height.
- Acute kidney injury or non-steady state: the weight correction does not fix the fact that Cockcroft–Gault assumes a stable serum creatinine.
- Drug-specific dosing: some drugs specify total or lean body weight regardless of obesity; always check the drug label.
Why Adjusted Body Weight Works
Creatinine is produced mainly by muscle, so the kidneys' apparent ability to clear it scales with lean mass more than with fat. In an obese patient, total body weight is dominated by adipose tissue that adds little to creatinine production or to the clearance of many drugs. Plug total body weight into the Cockcroft–Gault equation and the estimate is credited with clearance the kidneys do not actually provide. Using ideal body weight alone swings the other way and can underestimate, because a heavier person does carry some extra lean mass and a larger filtering surface. Adjusted body weight is the compromise: it starts from IBW and adds back a fraction of the excess so the weight input reflects the part of the extra mass that is metabolically active.
How the 0.4 Factor Is Chosen
The 0.4 coefficient means 40% of the weight above ideal is counted toward the dosing weight. It is a long-standing clinical convention rather than an exact physiological constant: it approximates the share of excess body mass that behaves like lean tissue for the purposes of drug distribution and clearance. Some agents and protocols use a different factor, so the value should be read as a sensible default, not a fixed law. Because AjBW always lies between IBW and actual weight, it never overshoots total body weight nor falls below the lean reference.
Comparison Across Body Sizes
Worked through for a fixed 70 kg ideal body weight, the adjustment grows with the degree of excess:
| Actual weight | Excess over IBW | AjBW |
|---|---|---|
| 85 kg | 15 kg | 76 kg |
| 100 kg | 30 kg | 82 kg |
| 120 kg | 50 kg | 90 kg |
| 150 kg | 80 kg | 102 kg |
In each row the AjBW sits between the 70 kg ideal and the actual weight, climbing slowly as the excess rises — which is the behaviour that keeps the creatinine clearance estimate realistic rather than inflated.
Putting AjBW to Work in Cockcroft–Gault
The practical workflow is short. First, calculate ideal body weight from the patient's height and sex. Compare it with the measured actual weight: if actual weight is below IBW, use actual weight; if it is normal-to-lean, use IBW; and if it exceeds roughly 1.2× IBW, calculate adjusted body weight with the 0.4 rule. Then enter that chosen weight — not necessarily the number on the scale — into the Cockcroft–Gault creatinine clearance equation along with age, sex, and serum creatinine. Choosing the weight deliberately is what keeps the clearance estimate, and any drug dose derived from it, appropriate for the patient's actual physiology rather than inflated by body fat. See creatinine clearance in obesity for the full clinical discussion.
Why Not Just Use Total Body Weight?
It is tempting to enter the number on the scale, but in obesity that choice systematically overstates clearance. Fat tissue is not metabolically inert, yet it produces little creatinine and contributes little to the clearance of most renally-eliminated drugs, so counting it in full credits the kidneys with work they are not doing. The result is an inflated creatinine clearance and, downstream, a drug dose that may be too high for the patient's true physiology. Adjusted body weight exists precisely to stop that error while still acknowledging the extra lean mass and larger filtering surface a heavier person genuinely carries.